These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Divergent effects of muscarinic receptor subtype gene ablation on murine colon tumorigenesis reveals association of M3R and zinc finger protein 277 expression in colon neoplasia. Cheng K; Xie G; Khurana S; Heath J; Drachenberg CB; Timmons J; Shah N; Raufman JP Mol Cancer; 2014 Apr; 13():77. PubMed ID: 24694019 [TBL] [Abstract][Full Text] [Related]
4. Type 3 muscarinic receptors contribute to intestinal mucosal homeostasis and clearance of Nippostrongylus brasiliensis through induction of TH2 cytokines. McLean LP; Smith A; Cheung L; Urban JF; Sun R; Grinchuk V; Desai N; Zhao A; Raufman JP; Shea-Donohue T Am J Physiol Gastrointest Liver Physiol; 2016 Jul; 311(1):G130-41. PubMed ID: 27173511 [TBL] [Abstract][Full Text] [Related]
5. Sodium taurocholate inhibits intestinal adenoma formation in APCMin/+ mice, potentially through activation of the farnesoid X receptor. Smith DL; Keshavan P; Avissar U; Ahmed K; Zucker SD Carcinogenesis; 2010 Jun; 31(6):1100-9. PubMed ID: 20194350 [TBL] [Abstract][Full Text] [Related]
6. Haploinsufficiency of Krüppel-like factor 5 rescues the tumor-initiating effect of the Apc(Min) mutation in the intestine. McConnell BB; Bialkowska AB; Nandan MO; Ghaleb AM; Gordon FJ; Yang VW Cancer Res; 2009 May; 69(10):4125-33. PubMed ID: 19435907 [TBL] [Abstract][Full Text] [Related]
7. Tensin4 (TNS4) is upregulated by Wnt signalling in adenomas in multiple intestinal neoplasia (Min) mice. Raposo TP; Alfahed A; Nateri AS; Ilyas M Int J Exp Pathol; 2020 Jun; 101(3-4):80-86. PubMed ID: 32567731 [TBL] [Abstract][Full Text] [Related]
8. Myh deficiency enhances intestinal tumorigenesis in multiple intestinal neoplasia (ApcMin/+) mice. Sieber OM; Howarth KM; Thirlwell C; Rowan A; Mandir N; Goodlad RA; Gilkar A; Spencer-Dene B; Stamp G; Johnson V; Silver A; Yang H; Miller JH; Ilyas M; Tomlinson IP Cancer Res; 2004 Dec; 64(24):8876-81. PubMed ID: 15604247 [TBL] [Abstract][Full Text] [Related]
9. Inhibiting vascular endothelial growth factor receptor-2 signaling reduces tumor burden in the ApcMin/+ mouse model of early intestinal cancer. Goodlad RA; Ryan AJ; Wedge SR; Pyrah IT; Alferez D; Poulsom R; Smith NR; Mandir N; Watkins AJ; Wilkinson RW Carcinogenesis; 2006 Oct; 27(10):2133-9. PubMed ID: 16782971 [TBL] [Abstract][Full Text] [Related]
11. Disruption of estrogen receptor signaling enhances intestinal neoplasia in Apc(Min/+) mice. Cleveland AG; Oikarinen SI; Bynoté KK; Marttinen M; Rafter JJ; Gustafsson JA; Roy SK; Pitot HC; Korach KS; Lubahn DB; Mutanen M; Gould KA Carcinogenesis; 2009 Sep; 30(9):1581-90. PubMed ID: 19520794 [TBL] [Abstract][Full Text] [Related]
12. Cables1 is a tumor suppressor gene that regulates intestinal tumor progression in Apc(Min) mice. Arnason T; Pino MS; Yilmaz O; Kirley SD; Rueda BR; Chung DC; Zukerberg LR Cancer Biol Ther; 2013 Jul; 14(7):672-8. PubMed ID: 23792637 [TBL] [Abstract][Full Text] [Related]
13. Inactivation of Itf2 promotes intestinal tumorigenesis in Apc(Min/+) mice. Grill JI; Herbst A; Brandl L; Kong L; Schneider MR; Kirchner T; Wolf E; Kolligs FT Biochem Biophys Res Commun; 2015 May; 461(2):249-53. PubMed ID: 25869068 [TBL] [Abstract][Full Text] [Related]
14. Type 3 Muscarinic Receptors Contribute to Clearance of Citrobacter rodentium. McLean LP; Smith A; Cheung L; Sun R; Grinchuk V; Vanuytsel T; Desai N; Urban JF; Zhao A; Raufman JP; Shea-Donohue T Inflamm Bowel Dis; 2015 Aug; 21(8):1860-71. PubMed ID: 25985244 [TBL] [Abstract][Full Text] [Related]
15. Epigenetic modulation of the retinoid X receptor alpha by green tea in the azoxymethane-Apc Min/+ mouse model of intestinal cancer. Volate SR; Muga SJ; Issa AY; Nitcheva D; Smith T; Wargovich MJ Mol Carcinog; 2009 Oct; 48(10):920-33. PubMed ID: 19378291 [TBL] [Abstract][Full Text] [Related]
16. Inactivation of the vitamin D receptor in APC(min/+) mice reveals a critical role for the vitamin D receptor in intestinal tumor growth. Zheng W; Wong KE; Zhang Z; Dougherty U; Mustafi R; Kong J; Deb DK; Zheng H; Bissonnette M; Li YC Int J Cancer; 2012 Jan; 130(1):10-9. PubMed ID: 21328347 [TBL] [Abstract][Full Text] [Related]
17. Chemopreventive efficacy of combined piroxicam and difluoromethylornithine treatment of Apc mutant Min mouse adenomas, and selective toxicity against Apc mutant embryos. Jacoby RF; Cole CE; Tutsch K; Newton MA; Kelloff G; Hawk ET; Lubet RA Cancer Res; 2000 Apr; 60(7):1864-70. PubMed ID: 10766173 [TBL] [Abstract][Full Text] [Related]
18. Role of c-Myc in intestinal tumorigenesis of the ApcMin/+ mouse. Ignatenko NA; Holubec H; Besselsen DG; Blohm-Mangone KA; Padilla-Torres JL; Nagle RB; de Alboránç IM; Guillen-R JM; Gerner EW Cancer Biol Ther; 2006 Dec; 5(12):1658-64. PubMed ID: 17106247 [TBL] [Abstract][Full Text] [Related]
19. Sunitinib malate inhibits intestinal tumor development in male Apc Chen L; Xu P; Xiao Q; Chen L; Li S; Jian JM; Zhong YB Int Immunopharmacol; 2021 Jan; 90():107128. PubMed ID: 33191180 [TBL] [Abstract][Full Text] [Related]
20. Deletion of the WNT target and cancer stem cell marker CD44 in Apc(Min/+) mice attenuates intestinal tumorigenesis. Zeilstra J; Joosten SP; Dokter M; Verwiel E; Spaargaren M; Pals ST Cancer Res; 2008 May; 68(10):3655-61. PubMed ID: 18483247 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]